Follow the people · Insider

BS

Brian C. Stephenson

Insider · Chief Financial Officer · FTH

Brian C. Stephenson files insider transactions with the SEC as a chief financial officer of Faeth Therapeutics (FTH). We hold 7 disclosed purchases and sales filed since 3 July 2019, 7 of them in the last 90 days.

  • Files forFTH
  • Disclosed buys and sells7 in all, 7 in the last 90 days
  • Last disclosure1 July 2026

Positions held

2 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 22 June 20261 July 2026Chief Financial Officer · Faeth Therapeutics (FTH)22 Form 4 lines · source: SEC Form 4
  • Filed 1 July 201925 February 2025CFO and Treasurer · BridgeBio Pharma (BBIO)169 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.